C10H14Br2
294.03 g/mol
Pharmaceutical IntermediateWarning
1,3-Dibromoadamantane
CAS876-53-9EC963-914-7
Category
Pharmaceutical Intermediate
Compound Class
Halocarbon
Primary Use
Pharmaceutical Intermediate
1,3-Dibromoadamantane is a brominated derivative of adamantane. It is primarily used as a pharmaceutical intermediate in the synthesis of other organic compounds.
Pharmaceutical intermediate
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 876-53-9
Related Compounds
ReferenceSame Category
4,6-Dichloro-5-pyrimidinecarboxylic acid
CAS87600-98-4
pharmaceutical intermediate
ReferenceSame Category
Benzyl [(azetidin-3-yl)methyl]carbamate
CAS876149-41-6
pharmaceutical intermediate
ReferenceSame Category
(R)-1-Benzyl-3-aminopiperidine dihydrochloride
CAS876160-18-8
pharmaceutical intermediate
ReferenceSame Category
Benzyl (3S)-3-[(tert-butoxycarbonyl)amino]piperidine-1-carboxylate
CAS876379-22-5
pharmaceutical intermediate
Safety Reference
Warning
H302Harmful if swallowed
H312Harmful in contact with skin
H315Causes skin irritation
H319Causes serious eye irritation
H332Harmful if inhaled
H335May cause respiratory irritation
Identifiers
IUPAC Name
1,3-dibromoadamantane
InChIKey
HLWZKLMEOVIWRK-UHFFFAOYSA-N
SMILES
C1C2CC3(CC1CC(C2)(C3)Br)Br
Synonyms (9)
- 1,3-Bromoadamantane
- 1,3-Dibromoadamantane
- Adamantane,3-dibromo-
- Memantine Impurity 46